← Browse by Condition
Medical Condition

recurrent epithelial ovarian cancer which includes epithelial ovarian fallopian tube and or primary peritoneal cancer

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1
NCT06366490 Phase 1
Recruiting

Safety and Immunogenicity of Innocell Autologous Cellular Immunotherapy for Recurrent Epithelial Ovarian Cancer

Enrollment
8 pts
Location
United States
Sponsor
PhotonPharma, Inc.
View Trial →